Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126938661 | 12693866 | 1 | I | 20160819 | 20160829 | 20160829 | PER | US-PFIZER INC-2016396288 | PFIZER | 68.00 | YR | M | Y | 112.00000 | KG | 20160829 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126938661 | 12693866 | 1 | PS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | Intravenous (not otherwise specified) | 2 MG, UNK (Q 15 MIN) | U | 19999 | 2 | MG | SOLUTION FOR INJECTION | ||||||
126938661 | 12693866 | 2 | SS | ATIVAN | LORAZEPAM | 1 | Intravenous (not otherwise specified) | 1 MG, UNK (Q 30 MIN) | U | 0 | 1 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126938661 | 12693866 | 1 | Dyspnoea |
126938661 | 12693866 | 2 | Anxiety |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126938661 | 12693866 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126938661 | 12693866 | Agitation | |
126938661 | 12693866 | Confusional state | |
126938661 | 12693866 | Delirium | |
126938661 | 12693866 | Mental status changes | |
126938661 | 12693866 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |